Libre Reaches 1.3M Users; Abbott Q4 ’18 Earnings Update
Abbott hosted its Q4 ’18 earnings call and provided brief updates on its diabetes business. Of note, Abbott disclosed that Libre now has >1.3M global users, +300k from the previous quarter. Below, FENIX provides a summary from the call as well as thoughts on Libre’s growth potential.
About The Author
Matthew has been a thought leader in the high-growth therapeutic areas of diabetes and cardiovascular medicine since 2006, making regular attendance at large and small CV/met scientific meetings and an architect of novel methods for assessing market opportunities. He has over a decade of experience in leading CV/met consulting engagements, is a published author in PM360 and Diabetes Technology & Therapeutics, and has been quoted in The Pink Sheet on anti-thrombotics.
If you receive our email blasts, you already have an account. Log in now
You can read the article’s full content online after purchase.